Yeddyurappa tells Goa minister to apologise, JD(S) slams Palyekar

Mangaluru, Apr 12: A 70-year-old woman who tested positive for COVID-19 got discharged from a hospital here on Sunday after she recovered from the novel coronavirus, said Dakshina Kannada Deputy Commissioner, Sindu B Rupesh.

Seven other patients have also recovered and discharged in Dakshina Kannada till date. Total number of active cases in the district has decreased to 5 now.

As many as 232 COVID-19 positive cases have been reported in Karnataka till date.

The total number of coronavirus cases in India on Sunday climbed to 8447, including 764 cured and discharged, 1 migrated and 273 deaths, said the Ministry of Health and Family Welfare.

Udupi, Feb 8: A rare sixth century granite idol of ‘Lajja Gauri’ has been discovered fixed on the road in Barkur village of Udupi district, according to information furnished by Dr. Shivakant Bajpai, Superintending Archaeologist of ASI Bangalore Circle. Lajja Gauri is depicted in nude form and is said to be a fertility symbol. The idol is rare, though very popular among certain cults.

Dr Shivakant Bajpai, who is on a tour of the coastal districts, said that he first came across the image when it went viral on social media. He subsequently traced it to a public road in Barkur, which is an ancient historical town of coastal Karnataka. It was the ancient capital of the Alupa kingdom and a seat of power for several centuries.

“This is a very important idol and hundreds of vehicles pass over it every day. We are rescuing it and I have issued an order to my local in-charge to keep it in safe custody. I have also sent a mail in this regard to the DC and SP of the district,” he said.

The idol is likely to be of 6th or 7th century, though further study is required to confirm a date, Dr. Bajpai said.

Lajja Gauri is a lotus-headed Hindu deity associated with abundance, fertility and sexuality, sometimes euphemistically described as Lajja ("modesty").

New Delhi, Jun 13: Loss of smell or taste has been added to the list of COVID-19 symptoms, according to the revised clinical management protocols released by the Union Health Ministry on Saturday.

The ministry said that coronavirus-infected patients reporting to various COVID-19 treatment facilities have been reporting symptoms like fever, cough, fatigue, shortness of breath, expectoration, myalgia, rhinorrhea, sore throat and diarrhea.

They have also complained of loss of smell (anosmia) or loss of taste (ageusia) preceding the onset of respiratory symptoms.

Older people and immune-suppressed patients in particular may present with atypical symptoms such as fatigue, reduced alertness, reduced mobility, diarrhoea, loss of appetite, delirium, and absence of fever, the ministry said.

Children might not have reported fever or cough as frequently as adults.

The US's national public health institute, the Centers for Disease Control and Prevention (CDC), had in early May incorporated "a new loss of taste or smell" in the list of COVID-19 symptoms.

According to the data from Integrated Health Information Platform and Integrated Disease Surveillance Programme, portal case investigation forms for COVID 19 (n=15,366), the details on the signs and symptoms reported are (as on June 11), fever (27 per cent), cough (21 pc), sore throat (10 pc), breathlessness (8 pc), Weakness (7 pc), running nose (3pc ) and others 24 pc.

According to the health ministry, people infected by the novel coronavirus are the main source of infection.

Direct person-to-person transmission occurs through close contact, mainly through respiratory droplets that are released when the infected person coughs, sneezes, or talks.

These droplets may also land on surfaces, where the virus remains viable. Infection can also occur if a person touches an infected surface and then touches his or her eyes, nose, or mouth.

The median incubation period is 5.1 days (range 2–14 days). The precise interval during which an individual with COVID-19 is infectious is uncertain.

As per the current evidence, the period of infectivity starts 2 days prior to onset of symptoms and lasts up to 8 days.

The extent and role played by pre-clinical/ asymptomatic infections in transmission still remain under investigation.